Boehringer Ingelheim Pharmaceuticals, Inc. and Connecticut Science Center announced the launch of an Innovation Lab, presented by Boehringer, a dedicated learning center designed to expand STEM (science, technology, engineering and mathematics) education opportunities for students and families across Connecticut.
Located within the Connecticut Science Center, the Innovation Lab will feature a curriculum focused on career pathways in human health, biology, and pharmaceutical sciences. Through hands-on learning experiences, interactive workshops and career-focused programming, the space will demonstrate how scientific discovery translates into medicines that transform patient lives while connecting classroom science to real-world career applications.
"At Boehringer, we think in generations. Investing in STEM education means investing in the future generation of innovators, creators and scientists," said Jean‑Michel Boers, President and CEO, Boehringer Ingelheim USA. "Connecticut has been our home for decades, and we remain committed to strengthening the state's STEM ecosystem and the broader scientific community. By expanding access and creating hands‑on learning experiences with local educators and industry partners, we are opening pathways for students and helping them see how science can make a meaningful, real‑world impact. This work is essential to building a stronger, healthier, and more sustainable future."
"Connecticut's future depends on the curiosity and creativity of the next generation of scientists, engineers, and innovators," said Matt Fleury, President & CEO of the Connecticut Science Center. "Through the Innovation Lab, we're creating more opportunities for students to explore the science behind medicines and see how discoveries in the lab lead to impactful outcomes for patients and communities. This will expand access to STEM learning and help inspire young people across Connecticut to imagine themselves shaping the future of science."